VENUS
The Venous thromboEmbolism Network U.S. (“VENUS”) is a collaborative U. S. research network organized under the auspices of the Hemostasis and Thrombosis Research Society, Inc. (“HTRS”).
The purpose of VENUS is to initiate and implement collaborative, multi-institutional, investigator-initiated clinical trials and/or other scientific research projects focused on thrombotic disorders in the United States (U.S.). VENUS members are individual physician-scientists employed at various academic medical or other non-commercial research institutions in the U.S. At present, there are an estimated 90 individual investigators employed at 60-70 institutions participating in VENUS.
VENUS members are organized into committees based on their research focus. Each VENUS committee is charged with organizing collaborative, multi-institutional research projects, including clinical trials, and applying for grant funds to support any proposed projects.
Council Members
Julie Jaffray, MD
Julie Jaffray is an Assistant Professor of Clinical Pediatric at Children’s Hospital, Los Angeles (CHLA). She undertook her pediatric residency at the University of Massachusetts Medical Center, and she completed her pediatric hematology/oncology fellowship at the combined Memorial Sloan Kettering Cancer Center/New York Presbyterian Hospital Weill Cornell program in New York. In July 2013, Dr. Jaffray spent an additional two years undertaking an advanced fellowship in pediatric hemostasis and thrombosis at CHLA.
Dr. Jaffray’s clinical and research interests are in the epidemiology and prevention of pediatric thrombosis. She is one of two U.S leaders for venous thrombosis prevention through The Children’s Hospitals Solutions for Patient Safety and has been one of the leaders for the pediatric subcommittee of VENUS. She has received funding for her research on VTE risk model building and prevention through the NIH as well as HTRS with a mentored research award.
Lisa Baumann Kreuziger, MD, MS
Lisa Baumann Kreuziger, MD is an Associate Medical Director at the BloodCenter of Wisconsin and Assistant Professor at the Medical College of Wisconsin - Division of Hematology and Oncology. She specializes in the treatment of clotting disorders and other benign hematology diseases. Dr. Baumann Kreuziger’s research interests involve optimal anticoagulation therapy for cancer patients with catheter-related thrombosis and understanding the mechanisms of thrombosis in heart failure patients with left ventricular assist devices (LVAD).
Subscribe